Philip Morris International posted a better-than-expected Q2 2026, with revenue of about $11.19 billion and adjusted EPS of $2.20, driven by strong performance in its smoke-free products and solid growth in international markets. Organic revenue rose roughly 7–7.6%, as the smoke-free segment led the gains and combustible products also contributed, contributing to a record quarterly sales level despite softer conditions in some markets. Management reaffirmed its full-year guidance, maintaining 5–7% organic revenue growth and 7–9% organic operating income growth, while updating the adjusted EPS outlook to about $8.26–$8.41 for 2026, though a Q3 EPS range of $2.20–$2.25 fell short of some analyst expectations. On a GAAP basis, earnings were pressured by a $511 million non-cash impairment charge related to RBH, pushing reported EPS lower even as the core business beat. Analysts reacted with price-target adjustments, and the stock moved higher on strong performance but trimmed gains in light of near-term guidance, underscoring investor focus on the smoke-free growth story versus near-term earnings trajectory.